Geode Capital Management
NDRA icon

Geode Capital Management’s ENDRA Life Sciences NDRA Stock Holding History

Geode Capital Management’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$98K Buy
+21,078
New +$83.5K ﹤0.01% 4144
2024
Q3 		– Sell
-44
Closed -$7.4K – 4564
2024
Q2 		$7.4K Buy
44
+13
+42% +$5.6K ﹤0.01% 4558
2024
Q1 		$31.5K Buy
31
+1
+3% +$1.96K ﹤0.01% 4405
2023
Q4 		$111K Buy
30
+2
+7% +$4.21K ﹤0.01% 4154
2023
Q3 		$55.3K Sell
28
-5
-15% -$10.7K ﹤0.01% 4396
2023
Q2 		$82.4K Buy
33
+22
+200% +$61.9K ﹤0.01% 4394
2023
Q1 		$42.9K Hold
11
– – ﹤0.01% 4554
2022
Q4 		$78K Buy
11
+1
+10% +$8.38K ﹤0.01% 4478
2022
Q3 		$105K Hold
10
– – ﹤0.01% 4547
2022
Q2 		$80K Buy
10
+1
+11% +$8.94K ﹤0.01% 4659
2022
Q1 		$126K Hold
9
– – ﹤0.01% 4569
2021
Q4 		$223K Hold
9
– – ﹤0.01% 4426
2021
Q3 		$559K Hold
9
– – ﹤0.01% 3980
2021
Q2 		$689K Buy
9
+2
+29% +$157K ﹤0.01% 3786
2021
Q1 		$666K Buy
7
+5
+250% +$375K ﹤0.01% 3711
2020
Q4 		$47K Hold
2
– – ﹤0.01% 4178
2020
Q3 		$46K Hold
2
– – ﹤0.01% 4027
2020
Q2 		$61K Hold
2
– – ﹤0.01% 3948
2020
Q1 		$46K Hold
2
– – ﹤0.01% 3939
2019
Q4 		$105K Hold
2
– – ﹤0.01% 3970
2019
Q3 		$66K Hold
2
– – ﹤0.01% 4030
2019
Q2 		$107K Buy
2
+1
+100% +$50.5K ﹤0.01% 3945
2019
Q1 		$84K Hold
1
– – ﹤0.01% 3932
2018
Q4 		$71K Buy
+1
New +$116K ﹤0.01% 3924

Other funds holding NDRA

ACM
Altium Capital Management New York $42M AUM
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Northwestern Mutual Wealth Management
Northwestern Mutual Wealth Management Milwaukee, Wisconsin $162B AUM 16.35% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $729M AUM 1,176.99% 1-Year Est. Return

Geode Capital Management's NDRA Position: Q1 2026 in Review

Geode Capital Management opened a new position in ENDRA Life Sciences (NDRA) in Q1 2026: 21,078 shares worth $98K. The stake represents ﹤0.01% of the portfolio and ranks #4144 among its holdings. This is a return to the name: Geode Capital Management previously reported a position in NDRA as recently as Q2 2024.

Geode Capital Management first reported a position in NDRA in Q4 2018 and has held it in 24 quarters since. The position peaked at $689K in Q2 2021. 8 funds tracked by Wall St. Rank hold NDRA as of Q1 2026.

  • Geode Capital Management held 21,078 shares of ENDRA Life Sciences worth $98K as of Q1 2026.
  • ENDRA Life Sciences was a new Geode Capital Management position in Q1 2026.
  • ENDRA Life Sciences made up ﹤0.01% of Geode Capital Management's portfolio in Q1 2026, its #4144 holding.
  • Geode Capital Management first reported a position in ENDRA Life Sciences in Q4 2018 and has held it in 24 quarters since.
  • Geode Capital Management's ENDRA Life Sciences position peaked at $689K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q1 2026.

Based on Geode Capital Management's 13F filing for Q1 2026, filed 15 May 2026.